NCT01495598 · OUTCOME
Area Under the Plasma Concentration Versus Time Curve (AUC) to the Last Timepoint (AUCLast)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEAN
- Unit
- hours*ng/mL
- Interval / dispersion
- Standard Deviation
- Time frame
- At pre-dose, 1, 2, 3, 4, 6, and 8 hours after dose on Cycle 1 Day 1, and pre-dose, 1, 2, 3, 4, 6, 8, and 24 hours after dose on Cycle 1 Day 15.
What was measured
Area under the plasma concentration versus time curve (AUC) was calculated using the log-linear trapezoidal method. The AUC is a measure of the serum concentration of the drug over time. It is used to characterize drug absorption.
Groups in this outcome
All Participants - Pomalidomide 5mg Daily
All participants treated with pomalidomide 5 mg by mouth (p.o.) for 21 of 28 days.
| Group | Source count |
|---|---|
| All Participants - Pomalidomide 5mg Daily | 28 |
Reported measurements
Cycle 1 Day 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| All Participants - Pomalidomide 5mg Daily | 466.5 | 304 | Not reported | Not reported | Not reported |
Cycle 1 Day 15
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| All Participants - Pomalidomide 5mg Daily | 504.5 | 325.9 | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 304
- value
- 466.5
- title
- Cycle 1 Day 1
- categories
- measurements
- group Id
- OG000
- spread
- 325.9
- value
- 504.5
- title
- Cycle 1 Day 15
- denoms
- counts
- group Id
- OG000
- value
- 28
- units
- Participants
- description
- Area under the plasma concentration versus time curve (AUC) was calculated using the log-linear trapezoidal method. The AUC is a measure of the serum concentration of the drug over time. It is used to characterize drug absorption.
- dispersion Type
- Standard Deviation
- groups
- description
- All participants treated with pomalidomide 5 mg by mouth (p.o.) for 21 of 28 days.
- id
- OG000
- title
- All Participants - Pomalidomide 5mg Daily
- param Type
- MEAN
- reporting Status
- POSTED
- time Frame
- At pre-dose, 1, 2, 3, 4, 6, and 8 hours after dose on Cycle 1 Day 1, and pre-dose, 1, 2, 3, 4, 6, 8, and 24 hours after dose on Cycle 1 Day 15.
- title
- Area Under the Plasma Concentration Versus Time Curve (AUC) to the Last Timepoint (AUCLast)
- type
- PRIMARY
- unit Of Measure
- hours*ng/mL
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle